Exelixis
EXEL
#1664
Rank
ยฃ9.22 B
Marketcap
ยฃ34.25
Share price
-0.58%
Change (1 day)
27.43%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) Fails to deliver data

Key failure to deliver metrics for Exelixis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Exelixis (EXEL) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Exelixis (EXEL) - since 2013

Volume in USD (price x number of shares), data since 2013

Exelixis (EXEL) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ14.16 M17.27%
2024ยฃ12.08 M86.29%
2023ยฃ6.48 M-41.81%
2022ยฃ11.14 M-31.9%
2021ยฃ16.36 M-20.71%
2020ยฃ20.64 M303.63%
2019ยฃ5.11 M-70.5%
2018ยฃ17.33 M8.82%
2017ยฃ15.92 M-17.35%
2016ยฃ19.27 M-75.68%
2015ยฃ79.23 M19.37%
2014ยฃ66.37 M258.49%
2013ยฃ18.51 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
GlaxoSmithKline
GSK
ยฃ61.56 Mยฃ0.39 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
ยฃ9.04 Mยฃ67.5 M๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ17.08 Mยฃ0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.67 Mยฃ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ21.81 Mยฃ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ57.52 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ29.26 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
ยฃ0 Mยฃ0.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
N/Aยฃ0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA